The perinatal period is a critical and often high-risk window for women experiencing substance use disorders (SUD), particularly opioid use disorder (OUD). Medications for opioid use disorder (MOUD) are well-established, evidence-based interventions that significantly reduce opioid use, prevent overdose, and support long-term recovery; however, many women in the perinatal period who could benefit from MOUD do not receive it. Participants will examine the physical health, behavioral health and social dimensions of treatment. Emphasis is placed on dispelling myths, reducing stigma, and strengthening interdisciplinary support for MOUD as a foundational component of care that improves both maternal and fetal outcomes. Behavioral Health providers who encounter perinatal clients in community mental health, primary care, hospital, correctional, and social service settings will strengthen their cross-disciplinary competencies and increase familiarity with MOUD prescribing pathways and referral networks. Participants will be better prepared to deliver compassionate, coordinated, and culturally responsive care that supports maternal recovery, infant well-being, and long-term family stability.